Bernstein raises Emerson stock price target on strong order growth

Bernstein raised its price target for Emerson Electric (NYSE: EMR) to $196 from $186, citing strong order growth of 14% in the latest quarter. The company reported adjusted earnings of $1.86 per share and revenue of $5.2 billion, both exceeding expectations. Management guided $3.8 billion in dividends and buybacks for fiscal 2027 and expressed confidence in meeting 2028 targets. Wells Fargo also raised its price target to $180, maintaining an Overweight rating.

Original reporting
Published Nov 5, 2026, 2:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 3:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EMR
Bullish
high confidence
Mentioned
$EMR
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EMRBullishMed
01

Why it matters

The target raise and order data provide a fresh catalyst for short‑term price appreciation.

02

Market read

Analyst upgrade on EMR could drive buying interest and modest upside.

03

What to watch

Potential headwinds in Europe and China could temper growth.

Relevance 7/10Novelty 7/10Timing: today

Background

Emerson reported 14% order growth, modest earnings beat, and raised dividend guidance, prompting analyst target revisions.

Company-level read

Ticker impact

$EMRBullishHigh confidence
Context

Bernstein raised its price target on Emerson Electric to $196, citing 14% order growth and strong quarterly results.

Expected impact

likely upward pressure as investors price in the higher target and strong order growth

Evidence & confidence

The new target and order growth are fresh data points that can prompt buying interest.

Market effects

Strong order growth may boost outlook for industrial automation sector.

Positive for US industrials and dividend‑focused investors.

Limited to Emerson and peers; no broader macro impact.

Counterpoint

The stock may be overvalued near its 52‑week high despite the upgrade.

Key entities

  • Emerson Electric Co.

    Industrial automation and engineering firm.

  • Bernstein

    Raised EMR price target to $196.

Related articles

$EMRMed

Emerson Electric (EMR) Stock: $162.61, Down 4.59% Nov 5 — JournalArta Global

Emerson Electric (EMR) stock fell 4.59% to $162.61 on November 5, 2026, testing support at $160.29. The stock's volume was 1.9× the 20-day average, and the MACD histogram turned negative. The company reported quarterly revenue of $4.87 billion, up 7.0% year-over-year, with net income of $718.0 million. Technical indicators suggest a neutral bias, with the stock above the 50-day average but below the 20-day average.

$EMRMedAI 8/10

Emerson Electric Q4 Earnings Call Highlights

Emerson Electric (EMR) reported Q4 underlying orders growth of 18% in software and systems, 13% in intelligent devices, with North America up 15% and Middle East up 42%. Backlog reached $8.2B, up 11% YoY. The company expects mid-single-digit sales growth in 2027, driven by growth verticals. Software and systems sales grew 14% in Q4, with margins expanding 490 bps to 32.3%.

$EMRMedAI 8/10

Emerson Electric Co (EMR) (Q4 2026) Earnings Call Highlights: Strong Orders

Emerson Electric (EMR) reported Q4 2026 earnings, highlighting strong orders and double-digit growth in some segments. Europe and China showed weakness, with sales down 1% in 2026. CEO Lal Karsanbhai expressed confidence in backlog growth but cautioned on regional challenges. Q1 2027 margin guidance is lower due to mix and investments. The company expects 5% underlying sales growth in 2027, with risks from the Middle East conflict. Corporate expenses were $45M higher than expected in Q4.

$EMRMed

Wells Fargo raises Emerson stock price target on secular tailwinds

Wells Fargo raised its price target on Emerson Electric (EMR) to $180 from $177, maintaining an Overweight rating. The firm cited strong secular tailwinds and positive price-to-cost dynamics. EMR's shares are near their 52-week high, with a year-to-date gain of nearly 30%. The company reported strong Q4 results, exceeding earnings and revenue estimates, but maintained a cautious outlook for 2027.

$EMRHighAI 8/10

Emerson Electric Q4 earnings beat as orders jump 14%

Emerson Electric (EMR) reported Q4 earnings of $1.86 per share, exceeding estimates, with revenue at $5.20bn. Orders rose 14% and backlog increased 11% to $8.2bn. The company guided fiscal 2027 adjusted EPS to $7.25. Shares were up 2.65% on the day. Management noted strong US demand but cautious international outlook.